Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Ionis Pharmaceuticals Inc | 1,105 |
| 2 | Merck and Co Inc | 704 |
| 3 | Sinochem Holdings Corp Ltd | 617 |
| 4 | C.H. Boehringer Sohn AG and Co KG | 608 |
| 5 | Pfizer Inc | 572 |
| 6 | Procter and Gamble Co | 520 |
| 7 | Purdue Pharma LP | 519 |
| 8 | Bayer AG | 420 |
| 9 | Amgen Inc | 415 |
| 10 | Bristol Myers Squibb Co | 345 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 16,604 |
| 2 | A61K | Medicinal preparations | 16,410 |
| 3 | C07D | Heterocyclic compounds | 7,084 |
| 4 | C12N | Microorganisms, enzymes | 3,389 |
| 5 | C07K | Peptides | 3,209 |
| 6 | C07C | Acyclic and carbocyclic compounds | 1,563 |
| 7 | A61L | Sterilising / disinfecting materials | 1,337 |
| 8 | Y02A | Climate change adaptation | 1,280 |
| 9 | A61Q | Cosmetics, personal care | 1,212 |
| 10 | G01N | Investigating / analysing materials | 1,146 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives | 2003 | Pfizer Inc | 42 |
| Use of carprofen and derivatives therof for treating or preventing articular degeneration | 2000 | Pfizer Inc | 5 |
| A kind of method that use biological enzyme stereoselectivity splits Carprofen enantiomer | 2017 | 3 | |
| Synthesis of carprofen | 2009 | 3 | |
| STABLE CARPROFEN COMPOSITION | 2004 | Zoetis Inc | 3 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 13 |
| 2017 | 15 |
| 2018 | 12 |
| 2019 | 16 |
| 2020 | 19 |
| 2021 | 8 |
| 2022 | 13 |
| 2023 | 9 |
| 2024 | 5 |
| 2025 | 3 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | P. Lees | Royal Veterinary College | 17 |
| 2 | Miguel A. Miranda | Universitat Politècnica de València | 8 |
| 3 | Quintin McKellar | University of Glasgow | 8 |
| 4 | B. Ludwig | Roche (Switzerland) | 6 |
| 5 | Paul Flecknell | Newcastle University | 6 |
| 6 | Francisco Boscá | Universitat Politècnica de València | 5 |
| 7 | Kristen M. Messenger | North Carolina State University | 5 |
| 8 | Lon V. Kendall | Colorado State University | 5 |
| 9 | Matthew D. Hall | National Institutes of Health | 5 |
| 10 | Dorothy Cimino Brown | University of Pennsylvania | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Development of a scale to evaluate postoperative pain in dogs | 1999 | 379 | Veterinary Pharmacology and Anesthesia |
| Self‐selection of the analgesic drug carprofen by lame broiler chickens | 2000 | 355 | Coccidia and coccidiosis research |
| Ability of the Canine Brief Pain Inventory to detect response to treatment in dogs with osteoarthritis | 2008 | 354 | Pain Mechanisms and Treatments |
| Effect of carprofen on lameness in broiler chickens | 1999 | 245 | Animal Nutrition and Physiology |
| Efficacy and Kinetics of Carprofen, Administered Preoperatively or Postoperatively, for the Prevention of Pain in Dogs Undergoing Ovariohysterectomy | 1998 | 239 | Anesthesia and Pain Management |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular structure and formula of carprofen?
Which companies hold the most patents related to carprofen?
What are the main research topics in published literature on carprofen?
Who are the most prolific authors publishing on carprofen?
What is the recent publication and patent trend for carprofen?